Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
07/2008
07/17/2008US20080171060 Lymphocyte receptor peptide for use in prevention and treatment of viral infection, cell proliferative, cardiovascular and allergic disorders; enhancing cytokine production
07/17/2008US20080171046 Novel proteins and nucleic acids encoding same
07/17/2008US20080171036 Using tumor necrosis factor specific immuoglobulin for diagnosis, treatment and prevention of inflammatory, cell proliferative, skin, respiratory system, nervous system and infectious disorders
07/17/2008US20080171021 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
07/17/2008US20080171014 Interleukin-13 binding proteins
07/17/2008DE202007003266U1 Pharmazeutische Zusammensetzung zum Schutz vor Allergien und entzündlichen Erkrankungen Pharmaceutical composition for protection against allergies and inflammatory diseases
07/17/2008CA2674647A1 Chemical compounds 637
07/17/2008CA2674644A1 Sulfonamide derivatives as chymase inhibitors
07/17/2008CA2674492A1 Method for the treatment of conditions associated with increased 5-lipoxygenase and/or leukotriene activity
07/17/2008CA2673803A1 Compounds and compositions as channel activating protease inhibitors
07/17/2008CA2672739A1 Methods of using il-31 to treat airway hyper-responsiveness and asthma
07/16/2008EP1944305A1 Quinoline derivatives as phosphodiesterase inhibitors
07/16/2008EP1944292A1 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents
07/16/2008EP1944291A1 Optically active cyclic alcohol compound and method for producing same
07/16/2008EP1944290A1 Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity
07/16/2008EP1944036A2 Improvements in and relating to drug delivery
07/16/2008EP1944018A1 Micronised particles of low-dosage strength active agents for powder formulations for inhalation
07/16/2008EP1943235A1 Arylurea derivatives as modulators of chemokine receptor activity
07/16/2008EP1942938A1 Use of oligouronates for treating mucus hyperviscosity
07/16/2008EP1942927A2 Method for discovering inhibitors of the epstein-barr virus-induced gene 3 (ebi3) and derivatives thereof for the treatment of metastasizing tumors and allergic asthma
07/16/2008EP1942909A2 Methods for treating respiratory disorders
07/16/2008EP1572739B1 Asthma susceptibility locus
07/16/2008EP1506205B1 Novel azacyclic ethynyl derivatives
07/16/2008EP1492500B1 Formoterol and ciclesonide aerosol formulations
07/16/2008EP1476541B1 Cytokine (zcytor17 ligand)
07/16/2008EP1471907B1 Use of c-kit inhibitors for treating autoimmune diseases
07/16/2008EP1392655B1 Potassium channel openers
07/16/2008EP1294383B1 Oral compositions comprising antimicrobial agents for the prevention of systemic diseases
07/16/2008EP1265603B1 Il-8 receptor antagonists
07/16/2008EP0748377B1 IMPROVED DNase LIQUID SOLUTIONS
07/16/2008CN101223443A Method for evaluating the effects of smoke on bronchioles
07/16/2008CN101223168A Heterocyclic JANUS kinase 3 inhibitors
07/16/2008CN101222927A Aerosolized fluoroquinolones and uses thereof
07/16/2008CN101220028A Urea substituted imidazopyridines
07/16/2008CN101220025A Micronized crystalline tiotropium bromide
07/16/2008CN101219985A N-substituted indole-3-glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating action
07/16/2008CN101219216A Method for preparing coexpression PRRSV ORF3 and ORF5 double-gene nucleic acid vaccine
07/16/2008CN101219203A Proprietary Chinese medicine for treating cough, asthma and tuberculosis
07/16/2008CN101219201A Traditional Chinese medicine liquid capsule and its preparing method
07/16/2008CN101219200A Traditional Chinese medicine soft capsule and its preparing method
07/16/2008CN101219193A Medicament for clearing heat, eliminating phlegm and relieving cough
07/16/2008CN101219189A Clinical application of Chinese medicinal herb for treating cancer of the lungs
07/16/2008CN101219188A Anti-inflammation antalgica liquid
07/16/2008CN101219168A Rumex gmelini turcz extracting technique and extract thereof
07/16/2008CN101219158A Application of Miao national herbs tarweed in preparing medicament for treating rhinitis
07/16/2008CN101219131A Method for applying calcium polyenoic acid for medical and beauty treatment fields
07/16/2008CN101219128A Dexibuprofen pharmaceutical composition with improved dissolving out capability and method for preparing the same
07/16/2008CN101219109A Oxolamine sirup and method for producing the same
07/16/2008CN101218951A Internal mixing loquat leaf and Sichuan fritillary bulb bonbon
07/16/2008CN100402643C 感染性克隆 Infectious clone
07/16/2008CN100402528C Urea substituted imidazopyridines
07/16/2008CN100402521C 4-imidazolin-2-one compounds
07/16/2008CN100402501C Aminoquinoline derivatives and their use as adenosine A3 ligands
07/16/2008CN100402499C 2-iminopyrrolidine derivatives
07/16/2008CN100402496C Compounds useful as matrix metalloprotease inhibitors
07/16/2008CN100402085C Production of high-concentration thymic peptide solution and large-specification thymic peptide preparation
07/16/2008CN100402083C Use of composition in prepaing Chinese medicinal product for preventing and treating wind cold cough
07/16/2008CN100402075C Pharynx clearing Chinese medicinal composition
07/16/2008CN100402073C Medicine for treating disease caused by heat toxin
07/16/2008CN100402048C Quality control method of composite prepn. of dry mango tree leaves extract
07/16/2008CN100402047C Extract of hippophae rhamnoides seed
07/16/2008CN100402025C Modified release pharmaceutical formulation
07/16/2008CN100401925C Making method of health-care beverage for efficient preventing and treating asthma
07/16/2008CN100401896C Methods of diagnosis and treatment of interstitial lung disease
07/15/2008US7399901 linker for activation of T- cells (lat genes and proteins), used for screening drug useful for treatment against asthma and allergies
07/15/2008US7399878 Pharmaceutical compounds
07/15/2008US7399782 Disease involving mucus transport
07/15/2008US7399779 3,6-disubstituted azabicyclo [3.1.0] hexane derivatives useful as muscarinic receptor antagonists
07/15/2008US7399756 Organo-phosphorous compounds for activating gamma/delta T cells
07/15/2008US7399464 Polypeptides of the IFNα-7 gene
07/15/2008CA2425560C Anticholinergics, processes for preparing them and their use as pharmaceutical compositions
07/15/2008CA2373296C Combination of nicotinic acid or nicotinamide with riboflavin for the treatment of pruritus, itching and inflammation disorders
07/15/2008CA2334411C Use of a composition comprising formoterol and budesonide for the prevention or treatment of an acute condition of asthma
07/15/2008CA2247848C Nitric oxide donors capable of reducing toxicity from drugs
07/15/2008CA2156083C Variants of bile salt-stimulated lipase, dna molecules encoding them, and transgenic non-human mammals
07/14/2008CA2675718A1 Combination of a muscarinic receptor antagonist and a beta-2-adrenoceptor agonist
07/10/2008WO2008083302A2 Use of adenosine deaminase for treating pulmonary disease
07/10/2008WO2008080461A1 5-phenyl-6-pyridin-4-yl-1,3-dihydro-2h-imidazo[4,5-b]pyridin-2-one derivatives useful as a2b adenosine receptor antagonists
07/10/2008WO2008080218A1 Methods of selecting and producing modified toxins, conjugates containing modified toxins and uses thereof
07/10/2008WO2008060371A8 USE OF TGF-β ANTAGONISTS TO TREAT INFANTS AT RISK OF DEVELOPING BRONCHOPULMONARY DYSPLASIA
07/10/2008WO2008053444A3 Treating a respiratory condition with bifidobacterium
07/10/2008WO2008037037A3 Anti-asthmatic medicine comprising i. a. caffeine, ergotamine, zinc, papaverine, atropine, aminophyyline, glaucine etc.
07/10/2008WO2002072778A3 Method for identifying inhibitors of g protein coupled receptor signaling
07/10/2008US20080167471 comprising 4-[4-[4-(Hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]- alpha , alpha -dimethylbenzeneacetic acid hydrochloride; antiallergic agents and bronchodilators
07/10/2008US20080167469 Preparing anhydrous 4-(4-(4-(Hydroxydiphenylmethyl)-1-piperidinyl)-1-hydroxybutyl)-alpha,alpha -dimethylbenzene acetic acid hydrochloride by azeotropic distillation of the corresponding hydrate
07/10/2008US20080167367 Stable hydrate of a muscarinic receptor antagonist
07/10/2008US20080167362 Time-release tablets or capsules also containing an opoid or analgesic; cyclooxygenase-2 inhibitors
07/10/2008US20080167359 guanidines such as (1H-benzoimidazol-2-yl)(2,6-dichlorophenyl)methylamine, used as proton pump inhibitors for prevention or treatment of respiratory system, sleep, urogenital or nervous ststem disorders; as antihypotensive, neuroleptic, antidepressants, anxiolytic, antiischemic or antilipemic agents
07/10/2008US20080167346 low molecular weight factor Xa specific blood clotting inhibitors; less side effects; 5-Chloro-thiophene-2-carboxylic acid [2-(1-isopropyl-piperidin-4-ylsulfamoyl)-ethyl]-amide; thromboembolic diseases or restenosis; antithrombotic agents
07/10/2008US20080167332 Novel Compounds 243
07/10/2008US20080167298 Medicaments for the treatment of chronic obstructive pulmonary disease
07/10/2008US20080167287 Imidazotriazines and imidazopyrimidines as kinase inhibitors
07/10/2008US20080167257 Therapy of acroparaesthsia, allergic (psoric) conditions, allergic reactions, alopecia, amnesia, anaphrodisia, angina, arthritis, asthenopia, biliary sycosis, burns, cancerous conditions, such as colon cancer, malignant melanoma and malignant nasal polyps, carpal tunnel syndrome, colds, conjunctivitis
07/10/2008US20080167230 treating asthma by administering a trefoil peptide, the human intestinal trefoil factor (ITF), cyclic peptides
07/10/2008US20080166768 Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof
07/10/2008US20080166387 Anti-angiogenic compositions and methods of use
07/10/2008US20080166353 Using immunoglobulin specific to receptor for OX-2 membrane glycoprotein as diagnostic and therapeutic tool for treatment and prevention of asthma, infection, allergies, skin and cell proliferative disorders
07/10/2008US20080166336 CD137 agonists to treat patients with IgE-mediated conditions
07/10/2008CA2673668A1 Methods of selecting and producing modified toxins, conjugates containing modified toxins and uses thereof
07/09/2008EP1942181A1 Bacterium causing poultry disease and vaccine derived thereof